Tag: Biomarker

Latest News

VBI Vaccines Announces Data from VBI-1901 Presented at AACR 2020: Partial Response Observed, Promising Biomarker Strategy Identified

Newsemia
CAMBRIDGE, Mass.–(BUSINESS WIRE)—- $VBIV–VBI Vaccines Inc. (Nasdaq: VBIV) (“VBI”) a commercial-stage biopharmaceutical company developing next-generation infectious disease and immuno-oncology vaccines, today announced that updated Part...
Pharma / Biotech

Therapeutic Efficacy of ABN401, a Highly Potent and Selective MET Inhibitor, Based on Diagnostic Biomarker Test in MET-Addicted Cancer.

Newsemia
Related Articles Therapeutic Efficacy of ABN401, a Highly Potent and Selective MET Inhibitor, Based on Diagnostic Biomarker Test in MET-Addicted Cancer. Cancers (Basel). 2020 Jun...
Gastroenterology

Combination of variations in inflammation- and endoplasmic reticulum-associated genes as putative biomarker for bevacizumab response in KRAS wild-type colorectal cancer

Newsemia
Combination of variations in inflammation- and endoplasmic reticulum-associated genes as putative biomarker for bevacizumab response in KRAS wild-type colorectal cancer Source link...
Cardiology

nAnnexin A1 is a Potential Novel Biomarker of Congestion in Acute Heart Failure.

Newsemia
Related Articles nAnnexin A1 is a Potential Novel Biomarker of Congestion in Acute Heart Failure. J Card Fail. 2020 May 27;: Authors: Adel FW, Rikhi...
Latest News

Study compares cediranib plus olaparib and standard of care therapy for platinum-sensitive ovarian cancer

Newsemia
Results of the NRG Oncology phase III clinical trial NRG-GY004 indicated that the addition of the investigational agent cediranib to olaparib and standard platinum-based chemotherapy...
Neurology

Research provides new evidence for potential blood-based biomarker for Alzheimer's

Newsemia
A potential blood-based biomarker for Alzheimer’s and other neurodegenerative diseases seems even more promising thanks to new research from a Massachusetts General Hospital-led study. Source...
Gastroenterology

Neoadjuvant modified FOLFIRINOX followed by postoperative gemcitabine in borderline resectable pancreatic adenocarcinoma: a Phase 2 study for clinical and biomarker analysis

Newsemia
Neoadjuvant modified FOLFIRINOX followed by postoperative gemcitabine in borderline resectable pancreatic adenocarcinoma: a Phase 2 study for clinical and biomarker analysis Source link...
Gastroenterology

Novel microRNA biomarker could help detect lymph node metastases in pancreatic cancer patients

Newsemia
For years, surgeons have operated on pancreatic cancer patients to remove what they thought was a localized tumor only to discover that the disease had...
Gastroenterology

The Pan-Immune-Inflammation Value is a new prognostic biomarker in metastatic colorectal cancer: results from a pooled-analysis of the Valentino and TRIBE first-line trials

Newsemia
The Pan-Immune-Inflammation Value is a new prognostic biomarker in metastatic colorectal cancer: results from a pooled-analysis of the Valentino and TRIBE first-line trials Source link...

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World